Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Bangash, Mansoor N ^a   Patel, Nimesh S A ^a   Benetti, Elisa ^b   Collino, Massimo ^b   Hinds, Charles J ^a   Thiemermann, Christoph ^a   Pearse, Rupert M ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD11B ANTIGEN; CREATININE; DOPEXAMINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTIC ACID; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UREA; DOPAMINE; PROTECTIVE AGENT; VASODILATOR AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; AORTA FLOW; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTOXEMIA; ENZYME ACTIVITY; HEMODYNAMICS; IMMUNOMODULATION; KIDNEY FUNCTION; KIDNEY INJURY; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER FUNCTION; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RESUSCITATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE LEVEL; UREA BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD FLOW; BLOOD FLOW VELOCITY; DRUG EFFECTS; INFLAMMATION; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; BLOOD FLOW VELOCITY; DOPAMINE; ENDOTOXEMIA; HEMODYNAMICS; INFLAMMATION; MALE; MICROCIRCULATION; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; VASODILATOR AGENTS;

EID: 84875354076     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12585     Document Type: Article

References (31)

1. Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft AF, Rhodes A. Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012, 380:1059-1165. 10.1016/S0140-6736(12)61148-9, 3493988, 22998715.
2. Pearse RM, Holt PJ, Grocott MP. Managing perioperative risk in patients undergoing elective non-cardiac surgery. BMJ 2011, 343:d5759. 10.1136/bmj.d5759, 21976704.
3. Jhanji S, Lee C, Watson D, Hinds C, Pearse RM. Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications. Intensive Care Med 2009, 35:671-677. 10.1007/s00134-008-1325-z, 18936911.
4. Shoemaker WC. Cardiorespiratory patterns of surviving and nonsurviving postoperative patients. Surg Gynecol Obstet 1972, 134:810-814.
5. Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH, Jensen JA, Jonsson K, Paty PB, Rabkin JM, Upton RA, von Smitten K, Whitney JD. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997, 132:997-1004. 10.1001/archsurg.1997.01430330063010, 9301613.
6. Jhanji S, Vivian-Smith A, Lucena-Amaro S, Watson D, Hinds CJ, Pearse RM. Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial. Crit Care 2010, 14:R151. 10.1186/cc9220, 2945135, 20698956.
7. Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993, 270:2699-2707. 10.1001/jama.1993.03510220055034, 7907668.
8. Takala J, Meier-Hellmann A, Eddleston J, Hulstaert P, Sramek V. Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study: European Multicenter Study Group on Dopexamine in Major Abdominal Surgery. Crit Care Med 2000, 28:3417-3423. 10.1097/00003246-200010000-00007, 11057795.
9. Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 1999, 318:1099-1103. 10.1136/bmj.318.7191.1099, 27840, 10213716.
10. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay: a randomised, controlled trial [ISRCTN38797445]. Crit Care 2005, 9:R687-R693. 10.1186/cc3887, 1414018, 16356219.
11. Davies SJ, Yates D, Wilson RJ. Dopexamine has no additional benefit in high-risk patients receiving goal-directed fluid therapy undergoing major abdominal surgery. Anesth Analg 2011, 112:130-138. 10.1213/ANE.0b013e3181fcea71, 21048092.
12. Pearse RM, Belsey JD, Cole JN, Bennett ED. Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Crit Care Med 2008, 36:1323-1329. 10.1097/CCM.0b013e31816a091b, 18379261.
13. Bangash MN, Kong ML, Pearse RM. Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol 2012, 165:2015-2033. 10.1111/j.1476-5381.2011.01588.x, 3413841, 21740415.
14. Oberbeck R, Schmitz D, Schuler M, Wilsenack K, Schedlowski M, Exton M. Dopexamine and cellular immune functions during systemic inflammation. Immunobiology 2004, 208:429-438. 10.1078/0171-2985-00290, 15124857.
15. Oberbeck R. Catecholamines: physiological immunomodulators during health and illness. Curr Med Chem 2006, 13:1979-1989. 10.2174/092986706777584997, 16842192.
16. Birnbaum J, Klotz E, Spies CD, Lorenz B, Stuebs P, Hein OV, Grundling M, Pavlovic D, Usichenko T, Wendt M, Kox WJ, Lehmann C. Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats. Crit Care 2006, 10:R117. 10.1186/cc5011, 1750974, 16893450.
17. Schmidt W, Hacker A, Gebhard MM, Martin E, Schmidt H. Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors. Crit Care Med 1998, 26:1639-1645. 10.1097/00003246-199810000-00012, 9781719.
18. Liu L, Kubes P. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb Haemost 2003, 89:213-220.
19. Murch O, Abdelrahman M, Collino M, Gallicchio M, Benetti E, Mazzon E, Fantozzi R, Cuzzocrea S, Thiemermann C. Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat. Crit Care Med 2008, 36:550-559. 10.1097/01.CCM.0B013E3181620D2F, 18216604.
20. Hofstetter C, Boost KA, Flondor M, Basagan-Mogol E, Betz C, Homann M, Muhl H, Pfeilschifter J, Zwissler B. Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand 2007, 51:893-899. 10.1111/j.1399-6576.2007.01353.x, 17635397.
21. Uusaro A, Russell JA. Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?. Intensive Care Med 2000, 26:299-304. 10.1007/s001340051153, 10823386.
22. Szabo C, Hasko G, Zingarelli B, Nemeth ZH, Salzman AL, Kvetan V, Pastores SM, Vizi ES. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 1997, 90:95-100. 10.1046/j.1365-2567.1997.00137.x, 1456713, 9038718.
23. Lauw FN, Pajkrt D, Hack CE, Kurimoto M, van Deventer SJ, van der Poll T. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000, 165:2783-2789.
24. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 1992, 149:1666-1670.
25. Trabold B, Gruber M, Frohlich D. Synthetic inotropes inhibit the expression of adhesion molecules and augment the expression of L-selectin in polymorphonuclear neutrophils. Resuscitation 2007, 74:352-356. 10.1016/j.resuscitation.2007.01.010, 17382451.
26. Jacinto SM, Chintala MS, Lokhandwala MF, Jandhyala BS. Efficacy and mechanisms of dopexamine in the prevention of ischemia-reperfusion induced organ damage: role of oxygen free radicals. Clin Exp Hypertens 1997, 19:181-190. 10.3109/10641969709080814, 9028645.
27. Kostopanagiotou G, Pandazi A, Andreadou I, Doufas A, Chondroudaki I, Kotsis T, Rizos D, Costopanagiotou C, Smyrniotis V. Effects of dopexamine on lipid peroxidation during aortic surgery in pigs: comparison with dopamine. Eur J Vasc Endovasc Surg 2005, 30:648-653. 10.1016/j.ejvs.2005.06.029, 16102983.
28. Liaw WJ, Tzao C, Wu JY, Chen SJ, Wang JH, Wu CC. Inhibition by terbutaline of nitric oxide and superoxide anion levels of endotoxin-induced organs injury in the anesthetized rat. Shock 2003, 19:281-8. 10.1097/00024382-200303000-00014, 12630530.
29. Palsson J, Ricksten SE, Houltz E, Lundin S. Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats. Acta Anaesthesiol Scand 1997, 41:392-398. 10.1111/j.1399-6576.1997.tb04705.x, 9113186.
30. Tracey KJ, Cerami A. Metabolic responses to cachectin/TNF: a brief review. Ann N Y Acad Sci 1990, 587:325-331.
31. Tracey KJ, Lowry SF, Fahey TJ, Albert JD, Fong Y, Hesse D, Beutler B, Manogue KR, Calvano S, Wei H, Cerami A, Shires GT. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987, 164:415-422.